Medrx (4586.T) traded down -3.85 % during a 24 hours period ending at 03:41 AM Central Europe on Tuesday 27th. One Medrx stock can currently be bought for about JPY 49 on popular exchanges. Current supply of Medrx stocks is 68.6 mn. Medrx has a current market capitalization of JPY 3.4 bn and approximately JPY 82.9 mn worth of Medrx was traded on exchanges in the last 24 hours. Since last month end, Medrx has traded -19.35 % down. Simple moving average of last 200 days is at JPY 79.1. The highest price of past 52 weeks was recorded at JPY 146 on 10/28/2025. 52 weeks low was at JPY 48 on 10/23/2026.

Here is how related stocks have performed in the past 24 hours:

  • Edia (3935.T) traded up 0.28 % and now trades at JPY 705. Edia has a market capitalisation of JPY 4.1 bn. Edia has a current price to earnings ratio of 10.37.

  • Hotman (3190.T) traded up 0.35 % and now trades at JPY 579. Current market capitalisation for Hotman is JPY 4.1 bn. Current price/earnings ratio for Hotman is 20.61.

  • Tokuden (3437.T) traded down -0.96 % and now trades at JPY 2,570. Current market capitalisation for Tokuden is JPY 4.1 bn. Tokuden has a current price to earnings ratio of 9.23.

  • Manebi (525A.T) traded flat 0 % and now trades at JPY 1,663. Current market capitalisation for Manebi is JPY 4.1 bn.

  • Opro (228A.T) traded up 1.1 % and now trades at JPY 1,760. Current market capitalisation for Opro is JPY 4.1 bn.

About Medrx

MedRx Co., Ltd is a Japanese pharmaceutical company that specializes in developing pharmaceutical drugs using the transdermal absorption system. The company is located in Higashikagawa and is part of the Health Care sector. MedRx’s primary focus is on creating medicines based on the ionic liquid transdermal system. Currently, the company has several products in its pipeline, including MRX-4TZT, which is in phase II; MRX-5LBT, which is phase III; MRX-10XT, which is in phase I; and MRX-7MLL, which is in the pre-clinical stage. In addition to these, MedRx offers micro needle patches for vaccine and/or API delivery through skin, as well as adhesive skin patches. The company was founded in 2002 and its headquarters is located in Higashikagawa, Japan.